CAMBRIDGE (UK) – Antibodies.com, a digital marketplace that enables life scientists to purchase critical research reagents at cost-effective prices from the primary manufacturers, today announced that is has raised £400,000 in pre-seed financing. Nidobirds Ventures, after successful investment in Labstep, joined local angel investors and industry veterans in the funding round. The funds will be […]
In a filing with the U.S. Security and Exchange Commission, the company reported that 12 investors participated in the funding round, which required no minimum investment. CEO Gary Pace, Ph.D., J.D., said that Cell Microsystems would use the funding to build out its commercial team with support and manufacturing personnel, as well as add sales […]
ST. PETERSBURG, Fla. — SRI International has been awarded a multi-year $11.6 million contract from the Defense Advanced Research Projects Agency (DARPA) to develop advanced chemical sensors that can support detection of chemical threats in complex urban environments. The system, called Localization and Characterization of Chemical Anomalies in Urban Settings (LOCCUS), will be developed under DARPA’s SIGMA+ Program. LOCCUS will be […]
CAMBRIDGE, Mass – Ultivue, the innovation leader in tissue biomarker identification and quantification assays for translational and pathology research labs, today announced the close of a $22 Million Series C funding led by new investor Northpond Ventures and fueled by existing investors including ARCH Venture Partners, 6 Dimensions Capital, Yonghua Capital, and Applied Ventures. The […]
Leader in biomedical machine learning will use additional funds to expand Toronto office, Toronto team, and global salesforce to service growing pharmaceutical customer base TORONTO BenchSci today announced additional investment from Gradient Ventures, Google’s AI-focused venture fund, that brings the company’s total funding to CAD $27.2 million (USD $20.5 million). BenchSci will use the additional […]
IsoPlexis is collaborating with leading academic medical centers and existing users to apply its revolutionary single-cell biology to cell therapy BRANFORD, Conn. — IsoPlexis, a company focused on advancing single-cell functional biomarkers to address critical challenges in oncology & beyond, today announced that it has received $4 million in grant funding from the National Cancer Institute’s Small Business Innovation […]
Veteran Team Reinventing Genetic Analysis Tools to Expand Access and Improve Quality SAN DIEGO, Calif.–Element Biosciences, Inc., a company focused on the development of genetic analysis tools secures $15 million in Series A funding led by Foresite Capital and Venrock. Proceeds from the financing will support the development of disruptive technologies designed to significantly improve quality […]
CALGARY – Nanalysis Scientific Corp. (TSXV: NSCI), is pleased to announce it has closed a non-brokered private placement with the Chairman of Factors Group. The Chairman of Factors Group stated “We are very pleased we are investing in Nanalysis Scientific. Factors Group is committed to producing the highest quality products possible and seeing worldwide improvement of testing in […]
Latest funding led by Agilent Technologies with participation from Cota Capital, 5AM Ventures, and Roche Venture Fund PLEASANTON, Calif. – Purigen Biosystems, Inc., a leading provider of next-generation technologies for extracting, enriching, and quantifying nucleic acids from biological samples, today announced the completion of a $26.4 million Series B financing. The latest round of funding was […]
New funding of $2.9 million USD (£2.2 million) is in addition to the $2 million (£1.5 million GBP) investment (announced in January 2019), brings the total raised to $4.8 million USD (£3.7 million GBP) Lead investors were Greenwood Way Capital and 24Haymarket Limited Funding will be used to further expand operations in the UK and USA […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
